Arcturus Therapeutics Holdings Inc. (ARCT) vs Editas Medicine, Inc. (EDIT)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Editas Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
EDIT
Editas Medicine, Inc.
$2.74HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ARCT vs EDIT
growth of $100 · dividends reinvested · last 10yARCT -19.5% (-2.1%/yr)EDIT -81.4% (-15.5%/yr)ARCT compounded faster over this window
ARCT EDIT
ARCT vs EDIT: by the numbers
- •EDIT is the larger company ($420M vs $373M market cap).
- •Both run net losses; EDIT's is the smaller (-157.32% vs -391.90% net margin).
- •ARCT grew revenue faster over the past five years (22.30% vs -10.34% CAGR).
Metrics side by side
Valuation
| Metric | ARCT | EDIT |
|---|---|---|
| P/S ratio | 15.69 | 8.95 |
| P/B ratio | 2.17 | 3.99 |
Profitability
| Metric | ARCT | EDIT |
|---|---|---|
| Gross margin | 95.50% | 100.00% |
| Operating margin | -111.51% | -245.15% |
| Net margin | -391.90% | -157.32% |
| ROE | -54.29% | -70.24% |
| ROIC | -54.07% | -48.61% |
Growth (annualized)
| Metric | ARCT | EDIT |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | -10.34% |
| Total return CAGR (5Y) | -18.73% | -40.76% |
Frequently asked
- Which has grown faster, ARCT or EDIT?
- Over the past five years, ARCT grew revenue faster — ARCT at a 22.30% CAGR versus EDIT at -10.34%.
- How have ARCT and EDIT total returns compared?
- Over the past 10 years, ARCT delivered -2.54% and EDIT delivered -15.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEEditas Medicine ROEArcturus Therapeutics operating marginEditas Medicine operating marginArcturus Therapeutics revenue growthEditas Medicine revenue growthArcturus Therapeutics free cash flowEditas Medicine free cash flow
Arcturus Therapeutics & Editas Medicine appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.